ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY BIOMARKER DEVELOPMENT & AGING RESEARCH
SKUNKWORKS FOR RADICAL INNOVATION IN HEALTHCARE
Artificial Intelligence for Drug Discovery and Aging Research

Our Mission is to Extend Healthy Longevity

We aspire to be the Bell labs of AI for healthcare and longevity
We provide services to academia, pharmaceutical and cosmetics companies:
  • Advanced deep learning solutions
  • Custom drug discovery engines
  • Custom biomarkers discovery
  • New tools for aging research
ai pharma pipeline
Pharmaceutical Pipeline Leads
Nutraceutical Pipeline Leads
bridging the pharmaceutical and consumer industries
Awards & Recognition
We are happy to give you best from our service which is based on serious experience.
ACS Editors' Choice
Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
Nvidia Top 5

AI Companies for Social Impact
Nvidia GTC 2015 Finalist
Deep Learning for Drug Discovery
Most Promising Company
at the Personalized Medicine World Conference 2015 in Palo Alto, CA
106 Artificial Intelligence Startups In Healthcare
From Virtual Nurses To Drug Discovery: 106 Artificial Intelligence Startups In Healthcare
Some of Our Current Projects
Over 150 Academic and Industry Collaborators Worldwide
Videos about Insilico Medicine
About Insilico Medicine
Chemistry AI
Life Extension Geroprotect Ageless Cell Launch
Geroprotect Partnership Between Life Extension and Insilico Medicine YouTube
Team
Alex Zhavoronkov, PhD
CEO
Qingsong Zhu, PhD
COO
Alex Aliper
President of EMEA
Marine Bozdaganyan, PhD
Head of Medical Chemistry
Ivan Ozerov, PhD
Director, Drug Discovery
Quentin Vanhaelen, PhD
Director, Virtual Human Project
We have 39 scientists hired through hackathons and competitions worldwide in the US, Poland, Belgium, and Russia. 30% of our staff are women.
Scientific Advisory Board
Charles Cantor, PhD
ex-Director of the Human Genome Project and the Center for Advanced Biotechnology at Boston University
Michael Levitt, PhD
2013 Nobel Laureate (Chemistry) Professor, Stanford University
Bud Mishra, PhD
Professor of computer science at Courant Institute, professor of biology at Mt. Sinai School of Medicine and NYU School of Medicine
Donald Small, MD, PhD
Director of pediatric oncology at the Johns Hopkins Kimmel Cancer Center
Yuri Nikolsky, PhD
Co-founder, GeneGo, ex-VP Thomson Reuters Director, Skolkovo Found
Kristen Fortney, PhD
Postdoctoral fellow of Ellison Medical Foundation/American Federation for Aging Research at Stanford University
Alexey Moskalev, PhD
Professor at Syktyvkar State University
Head of the laboratory of Molecular radiobiology and gerontology at the Institute of biology of Komi Science Center of Ural division of RAS
Ulrich Muehlner, PhD
Founder at GrowthCube Partners
Previously Director Global Corporate Strategy at Novartis and with The Boston Consulting Group (BCG)

A ranking of the 100 most promising private artificial intelligence companies in the world

Oct. 30, 2017, London, UK: Biogerontology Research Foundation (bg-rf.org.uk) Chief Science Officer, Dr. Alex Zhavoronkov and Biogerontology Research Foundation Advisor and Head of Business Development for Juvenescence ...

Insilico Medicine, a leader in the field of artificial intelligence, will present at the Singularity University Exponential Medicine Program in San Diego on Wednesday November 8 in Session XVIII - Future of Pharma

Insilico Medicine will present at The World Congress on Targeting Metabesity in London, UK on Tuesday, Oct. 31 in Session VIII: Are New Business Models Needed?

Insilico Medicine to use Artificial Intelligence platform to discover new Amyotrophic Lateral Sclerosis therapies.

Insilico Medicine is adapting best neural network architectures. These advances are usually integrated into a comprehensive drug discovery pipeline with the goal to enable the deep neural networks to produce perfect ...

Biogerontology Research Foundation Trustee Jim Mellon announces the publication of his newest book, Juvenescence: Investing in the Age of Longevity.

Insilico Medicine launched the Beta 1.0 version of YOUNG.AI on September 12th, 2017
Selected Publications
Upcoming Conferences
December 11-12, 2017 Boston, USA AI Applications Summit
USA CB Insights A!Ha (will register to attend) AI company awards day
December 12 San Francisco, USA CB Insights A!Ha (will register to attend) AI company awards day
December 15-16, 2017, Las Vegas, USA, A4M World Congress
Insilico Medicine, Inc.
Emerging Technology Centers
Johns Hopkins University Eastern Campus
Suite B301, 1101 East 33rd St.
Baltimore, MD 21218
Phone: +1 443 451 7212
Fax: +1 443 451 7210
Email: zhu@insilicomedicine.com
All photo and video materials belong to their owners and are used for demonstration purposes only. Please do not use them in commercial projects.
Made on
Tilda